POS1236 THE IMPACT OF ANTI-SARS-COV-2 VACCINES IN A MULTICENTER COHORT STUDY OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
M. Gerosa, T. Schioppo, Lorenza Maria Argolini, S. Sciascia, Giuseppe A. Ramirez, Gabriella Moroni, Renato Alberto Sinico, Federico Alberici, Luca Moroni, Francesco Tamborini, Paolo Miraglia, Chiara Bellocchi, Lorenzo Beretta, Dario Roccatello, L. Dagna, E. Bozzolo, R. Caporali
Topics & Concepts
MedicineBelimumabInternal medicineSystemic lupus erythematosusLupus nephritisAdverse effectRheumatologyHydroxychloroquinePrednisoneCohortImmunologyCoronavirus disease 2019 (COVID-19)DiseaseAntibodyInfectious disease (medical specialty)B cellB-cell activating factorSystemic Lupus Erythematosus ResearchSARS-CoV-2 and COVID-19 ResearchHepatitis Viruses Studies and Epidemiology